RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+63.95%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$4.18B
AUM Growth
+$4.18B
(+40%)
Cap. Flow
+$288M
Cap. Flow
% of AUM
6.88%
Top 10 Holdings %
Top 10 Hldgs %
48.69%
Holding
89
New
15
Increased
28
Reduced
14
Closed
24
Top Buys
| 1 |
Biogen
BIIB
|
$136M |
| 2 |
PRNB
Principia Biopharma Inc. Common Stock
PRNB
|
$106M |
| 3 |
Aprea Therapeutics
APRE
|
$104M |
| 4 |
Boston Scientific
BSX
|
$73.8M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$63.9M |
Top Sells
| 1 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$155M |
| 2 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$139M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$114M |
| 4 |
CELG
Celgene Corp
CELG
|
$55.9M |
| 5 |
WMGI
Wright Medical Group Inc
WMGI
|
$49.6M |
Sector Composition
| 1 | Healthcare | 98.47% |
| 2 | Industrials | 0.33% |
| 3 | Technology | 0% |
| 4 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PRAH
26
DELISTED
PRA Health Sciences, Inc.
PRAH
| $50M | 1.2% |
449,800
+54,400
| +14% | +$6.05M |
|
|
AXNX
27
DELISTED
Axonics, Inc. Common Stock
AXNX
| $42.5M | 1.02% |
1,532,000
+722,300
| +89% | +$20M |
|
28
HCA Healthcare
HCA
$94.7B
| $42.2M | 1.01% |
285,200
+49,700
| +21% | +$7.35M |
|
29
PTC Therapeutics
PTCT
$4.34B
| $41.3M | 0.99% |
+859,526
| New | +$41.3M |
|
|
EIDX
30
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
| $40.2M | 0.96% |
701,178
-221,825
| -24% | -$12.7M |
|
31
Replimune Group
REPL
$457M
| $39.7M | 0.95% |
2,766,407
+552,990
| +25% | +$7.94M |
|
32
Scholar Rock
SRRK
$3.32B
| $38.8M | 0.93% |
2,940,889
+83,500
| +3% | +$1.1M |
|
|
BOLD
33
DELISTED
Audentes Therapeutics, Inc
BOLD
| $38.2M | 0.91% |
639,095
-2,323,560
| -78% | -$139M |
|
34
Guardant Health
GH
$8.21B
| $30.5M | 0.73% |
+389,700
| New | +$30.5M |
|
35
Elevance Health
ELV
$71.9B
| $30.4M | 0.73% |
+100,800
| New | +$30.4M |
|
|
AMED
36
DELISTED
Amedisys
AMED
| $30.2M | 0.72% |
181,065
+178,745
| +7,705% | +$29.8M |
|
37
Cigna
CI
$79.8B
| $30.2M | 0.72% |
+147,500
| New | +$30.2M |
|
38
Ardelyx
ARDX
$1.55B
| $30M | 0.72% |
+4,000,000
| New | +$30M |
|
39
Stoke Therapeutics
STOK
$1.1B
| $28.9M | 0.69% |
1,020,778
+3,300
| +0.3% | +$93.5K |
|
|
GRTS
40
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $28M | 0.67% |
3,116,594
+12,100
| +0.4% | +$109K |
|
41
Wave Life Sciences
WVE
$1.23B
| $26.7M | 0.64% |
3,326,493
+148,733
| +5% | +$1.19M |
|
42
Akero Therapeutics
AKRO
$3.6B
| $25.8M | 0.62% |
1,164,002
-400
| -0% | -$8.88K |
|
|
TCRR
43
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $25.7M | 0.61% |
1,799,188
+8,900
| +0.5% | +$127K |
|
|
ODT
44
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $25.6M | 0.61% |
790,071
+16,500
| +2% | +$535K |
|
|
SWAV
45
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $24.9M | 0.6% |
+567,900
| New | +$24.9M |
|
46
Neurogene
NGNE
$276M
| $23.7M | 0.57% |
+1,920,831
| New | +$23.7M |
|
|
HOOK
47
DELISTED
HOOKIPA Pharma
HOOK
| $23.1M | 0.55% |
1,892,521
-5,200
| -0.3% | -$63.6K |
|
48
Xeris Biopharma Holdings
XERS
$1.26B
| $21.2M | 0.51% |
3,000,641
| – | – |
|
49
Genmab
GMAB
$16.6B
| $20.9M | 0.5% |
936,700
-311,900
| -25% | -$6.96M |
|
50
Cabaletta Bio
CABA
$137M
| $20M | 0.48% |
+1,431,696
| New | +$20M |
|